Olanzapine use in the elderly: A retrospective analysis

被引:28
作者
Solomons, K
Geiger, O
机构
[1] Univ British Columbia, Div Geriatr Psychiat, Vancouver, BC V6T 2B5, Canada
[2] Riverview Hosp, Div Geriatr, Vancouver, BC, Canada
来源
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 2000年 / 45卷 / 02期
关键词
olanzapine; elderly; psychosis; refractory; dementia;
D O I
10.1177/070674370004500205
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To evaluate the efficacy and safety of olanzapine in a hospitalized geriatric population that had previously failed to respond to, or tolerate, numerous trials with other antipsychotic medications. Method: A retrospective chart analysis was conducted on 58 elderly patients with psychotic symptoms who were given a trial on olanzapine. Data was collected regarding patients 'psychiatric diagnoses, duration of illness, duration of hospitalization, prior response to psychotropic therapies, concomitant psychotropic agents, side effects, and clinically determined changes over time. Results: Results indicated that 60.3% of this refractory group of patients improved on olanzapine. Side effects were reported for 38% of the patients, with delirium, extrapyramidal symptoms (EPS), and drowsiness or lethargy being the most common. Conclusions: The reported level of improvement in this group of refractory elderly. psychotic patients indicates that olanzapine can make an important contribution to the mental health of elderly patients with similar characteristics.
引用
收藏
页码:151 / 155
页数:5
相关论文
共 14 条
  • [1] ALLEN NHP, 1995, REV CLIN GERONTOLOGY, V5, P52
  • [2] Beasley CM, 1997, J CLIN PSYCHIAT, V58, P13
  • [3] Beasley CM, 1997, J CLIN PSYCHIAT, V58, P7
  • [4] Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia
    Conley, RR
    Tamminga, CA
    Bartko, JJ
    Richardson, C
    Peszke, M
    Lingle, J
    Hegerty, J
    Love, R
    Gounaris, C
    Zaremba, S
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (07) : 914 - 920
  • [6] Olanzapine: A new antipsychotic agent with efficacy in the management of schizophrenia
    Kando, JC
    Shepski, JC
    Satterlee, W
    Patel, JK
    Reams, SG
    Green, AI
    [J]. ANNALS OF PHARMACOTHERAPY, 1997, 31 (11) : 1325 - 1334
  • [7] Newer antipsychotics and antidepressants for elderly people
    Lacro, JP
    Eastham, JH
    Jeste, DV
    Lohr, JB
    [J]. CURRENT OPINION IN PSYCHIATRY, 1996, 9 (04) : 290 - 293
  • [8] Olanzapine: A novel atypical neuroleptic agent
    Reus, VI
    [J]. LANCET, 1997, 349 (9061) : 1264 - 1265
  • [9] Small GW, 1997, JAMA-J AM MED ASSOC, V278, P1363, DOI 10.1001/jama.278.16.1363
  • [10] New atypical antipsychotics - Experience and utility in the elderly
    Sweet, RA
    Pollock, BG
    [J]. DRUGS & AGING, 1998, 12 (02) : 115 - 127